Novel Treatment of Infant With COVID-19 With the Sialidase Fusion Protein, DAS181.
Danziger-Isakov, L; Khalil, N; Divanovic, A; Frenck, R; Grimley, M; Iliopoulos, I; Marsh, R; Paulsen, G; Phillips, CL; Schulert, G; et al.
Pediatric Infectious Disease Journal.
2021;
40:e234-e235.
Hyperdiploid Precursor B-acute Lymphoblastic Leukemia Presenting as a Cavernous Sinus Mass in a 4-Year-old Male.
Sabulski, A; Bartlett, AL; Koch, BL; Vatner, R; Mizukawa, B; Phillips, CL.
Journal of Pediatric Hematology/Oncology.
2021;
43:e494-e497.
Use of CD19-directed CAR T-Cell Therapy in an Infant With Refractory Acute Lymphoblastic Leukemia.
Breese, EH; Krupski, C; Nelson, AS; Perentesis, JP; Phillips, CL.
Journal of Pediatric Hematology/Oncology.
2021;
43:152-154.
Hyperdiploid Precursor B-acute Lymphoblastic Leukemia Presenting as a Cavernous Sinus Mass in a 4-Year-old Male.
Sabulski, A; Bartlett, AL; Koch, BL; Vatner, R; Mizukawa, B; Phillips, CL.
Journal of Pediatric Hematology/Oncology.
2021;
43:e494-e497.
Chimeric Antigen Receptor T Cell Therapy in Patients with Multiply Relapsed or Refractory Extramedullary Leukemia.
Rubinstein, JD; Krupski, C; Nelson, AS; O'Brien, MM; Davies, SM; Phillips, CL.
Biology of Blood and Marrow Transplantation.
2020;
26:e280-e285.
Genomic Variants of Cytarabine Sensitivity Associated with Treatment-Related Mortality in Pediatric AML: A Report from the Children's Oncology Group.
Phillips, CL; Lane, A; Gerbing, RB; Alonzo, TA; Wilkey, A; Radloff, G; Lange, B; Gamazon, ER; Dolan, ME; Davies, SM.
Clinical Cancer Research.
2020;
26:2891-2897.
Methylation profiling of hypomethylating agent response and treatment failure in pediatric and young adult MDS/AML.
Jones, LM; O'Brien, MM; Breese, EH; Absalon, M; Burns, KC; Grimley, M; Mizukawa, B; Lee, LH; Perentesis, JP; Phillips, CL.
Journal of Clinical Oncology.
2020;
38:e22502-e22502.
Chimeric antigen receptor T-cell therapy in patients with neurologic comorbidities.
Rubinstein, JD; Nelson, AS; Krupski, C; O'Brien, W; Taylor, JM; Badgett, TC; Huang, M; Davies, SM; Phillips, CL.
Pediatric Blood and Cancer.
2020;
67.
Reducing minimal residual disease with blinatumomab prior to HCT for pediatric patients with acute lymphoblastic leukemia.
Keating, AK; Gossai, N; Phillips, CL; Maloney, K; Campbell, K; Doan, A; Bhojwani, D; Burke, MJ; Verneris, MR.
Blood Advances.
2019;
3:1926-1929.
Reduced Fertility Potential in Young Patients Following Hematopoietic Stem Cell Transplantation Despite Reduced Intensity Conditioning.
Toro, HO-D; Howell, JC; Badia, P; Benoit, J; Davies, S; Grimley, M; Jodele, S; Phillips, C; Burns, K; Khandelwal, P; et al.
Journal of Pediatric and Adolescent Gynecology.
2018;
31.